Related references
Note: Only part of the references are listed.A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation
Jessica Knight-Perry et al.
BONE MARROW TRANSPLANTATION (2020)
Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial
Andreas H. Groll et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children
Sophida Boonsathorn et al.
CLINICAL PHARMACOKINETICS (2019)
A pharmacokinetic model for voriconazole in a highly diversified population of children and adolescents with cancer
Fabianne Altruda de Moraes Costa Carlesse et al.
MYCOSES (2019)
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
Antonio C. Arrieta et al.
PLOS ONE (2019)
ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children
A. Warris et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation
N. Decembrino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants
Jacqueline G. Gerhart et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial
S. Leroux et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children
Silke Gastine et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO
Kevin M. Watt et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Fluconazole Population Pharmacokinetics and Dosing for Prevention and Treatment of Invasive Candidiasis in Children Supported with Extracorporeal Membrane Oxygenation
Kevin M. Watt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation
Hyery Kim et al.
CLINICAL DRUG INVESTIGATION (2015)
Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch Regimens in Immunocompromised Japanese Pediatric Patients
Masaaki Mori et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Posaconazole Concentrations in Human Tissues after Allogeneic Stem Cell Transplantation
Ola Blennow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Physiologically Based Pharmacokinetic Model for Voriconazole Disposition Predicts Intestinal First-pass Metabolism in Children
Nicole R. Zane et al.
CLINICAL PHARMACOKINETICS (2014)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
W. W. Hope et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
G. Krishna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Pharmacokinetics and Safety of Fluconazole in Young Infants Supported With Extracorporeal Membrane Oxygenation
Kevin M. Watt et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Fluconazole Loading Dose Pharmacokinetics and Safety in Infants
Lauren Piper et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients
Claudia Michael et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Michael Neely et al.
CLINICAL INFECTIOUS DISEASES (2010)
In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3
Souzan B. Yanni et al.
DRUG METABOLISM AND DISPOSITION (2010)
Population Pharmacokinetics of Fluconazole in Young Infants
K. C. Wade et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Posaconazole concentrations in the central nervous system
Maria J. G. T. Rueping et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-β-cyclodextrin in infants, children, and adolescents
Susan M. Abdel-Rahman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Ontogeny of drug elimination by the human kidney
N Chen et al.
PEDIATRIC NEPHROLOGY (2006)
Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients
Stefanie Hennig et al.
CLINICAL PHARMACOKINETICS (2006)
Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis
SP Conway et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil)
A Ghosal et al.
DRUG METABOLISM AND DISPOSITION (2004)
Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults
R Courtney et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans
SM Hariprasad et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
L Purkins et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pharmacokinetic changes during extracorporeal membrane oxygenation - Implications for drug therapy of neonates
ML Buck
CLINICAL PHARMACOKINETICS (2003)
Reducing mortality in Salmonella enterica serovar typhimurium-infected mice with a tripeptidic serum fraction
TA Parker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (vol 45, pg 3122, 2001)
M Imwong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
